Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism NPY2R antagonists(Neuropeptide Y receptor type 2 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC27H23ClN2O3S |
InChIKeyZQJTYJZLKBRKPC-UHFFFAOYSA-N |
CAS Registry831194-71-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anxiety Disorders | Preclinical | US | 13 Jan 2009 |